Recent developments in health and medicine include new FDA approvals for diabetes and eye treatments, alongside concerns regarding dietary guidelines and healthcare access disparities.

A physicians group has initiated a lawsuit challenging the 2025-2030 Dietary Guidelines for Americans, citing concerns over potential conflicts of interest and a lack of transparency in the development process.

Cervical cancer screening rates are increasing, yet significant disparities persist among Native American, Alaska Native, Native Hawaiian, and Pacific Islander populations, as well as those living in Western and Southern US regions.

The FDA has granted approval for the use of satralizumab to treat thyroid eye disease, marking a continued expansion in therapeutic options for this condition.

Adults with insulin-treated type 2 diabetes now have access to the newly FDA-cleared twiist Automated Insulin Delivery System to assist in glucose management.

Brytly, an over-the-counter eye drop containing apraclonidine, has been approved for the treatment of eye redness in adults and children aged 12 and older.

New research indicates that most women diagnosed with inflammatory bowel disease (IBD) can achieve successful pregnancies through fertility treatments, regardless of prior pelvic surgery or active disease status.

Sunscreen containing the ingredient bemotrizinol is now available in US stores, offering consumers improved UVA protection and a more favorable cosmetic feel.

The All-Party Parliamentary Group (APPG) on Pharmacy is pressing the government to release a delayed response regarding policies that would allow pharmacists to substitute drug strengths or formulations.